The WT C57BL/6 develop NAFLD/NASH like pathology on HFD in association with enhanced Chi3L1 gene expression levels which allowed us to access the role of this gene in the pathogenesis of insulin resistance. Here, CHI3L1 is linked to metabolic dysfunction-associated steatotic liver disease.